Seattle, WA, United States of America

Mark Benoit


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mark Benoit: Innovator in Drug Diversion Detection

Introduction

Mark Benoit is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of drug diversion detection, holding 2 patents that focus on improving the management of controlled substances in medical facilities.

Latest Patents

Benoit's latest patents include a method and apparatus for detecting suspicious activities surrounding the management of controlled substances. This innovative approach involves flagging activities that may indicate the diversion of controlled drugs for further review. The detection process utilizes application layer network packets related to controlled substances on the medical facility network. By identifying the physical location of the packet's origin and processing these packets with a rules engine and machine learning-generated rules, Benoit’s inventions aim to determine if the circumstances surrounding the packets suggest potential diversion of controlled substances.

Career Highlights

Mark Benoit is currently employed at Bottomline Technologies Limited, where he continues to develop solutions that enhance the security and integrity of drug management systems. His work is pivotal in addressing the challenges faced by medical facilities in monitoring controlled substances.

Collaborations

Benoit collaborates with talented individuals such as Benjamin J Smith and Shawn Curtiss, contributing to a dynamic team focused on innovation in healthcare technology.

Conclusion

Mark Benoit stands out as an inventor dedicated to advancing drug diversion detection methods. His work not only enhances the safety of medical facilities but also contributes to the broader field of healthcare technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…